Ethinylestradiol/norethisterone acetate

From Wikipedia, the free encyclopedia
  (Redirected from Estrostep)
Jump to: navigation, search
Ethinylestradiol/norethisterone acetate
Combination of
Ethinylestradiol Estrogen
Norethisterone acetate Progestogen
Clinical data
Trade names Anovlar, Blisovi, Cumorit, Estrostep, FemHRT, Fyavolv, Gildess, Junel, Larin, Leribane, Loestrin, Mibelas, Microgestin, Minastrin, Norlestrin, Primodos, Taytulla, Tri-Legest
Pregnancy
category
  • US: X (Contraindicated)
Routes of
administration
Oral (pill)
Legal status
Legal status
Identifiers
CAS Number
PubChem CID

Ethinylestradiol/norethisterone acetate (brand names Estrostep, Gildess, Junel, Loestrin, Microgestin, Minastrin, many others) is a combination of the estrogen ethinylestradiol and the progestin norethisterone acetate (norethindrone acetate) which is marketed under a large number of brand names throughout the world for use as a combined oral contraceptive.[1][additional citation needed] In addition, the combination is marketed in the United States under the brand name FemHRT for use in hormone replacement therapy for menopausal symptoms.[1]

See also[edit]

References[edit]

  1. ^ a b "Drugs@FDA: FDA Approved Drug Products" (HTML). United States Food and Drug Administration. Retrieved 22 December 2016.